Gardasil Vaccine Lawsuit Guide 2026
Gardasil, introduced by Merck & Company, is advertised as a significant advancement against human papillomavirus and cervical cancer. Despite the vaccine’s recognition, concerns about its safety persist, leading to legal actions. Alleged severe effects, such as cervical cancer and autoimmune diseases, have sparked numerous lawsuits. Plaintiffs assert that Merck concealed health risks while falsely promoting it as a preventive solution. If you or a loved one is affected, consulting a personal injury attorney is crucial. In this comprehensive guide, EOL.Law explores the complexities of a Gardasil vaccine lawsuit and compensation, providing valuable insights for those seeking legal recourse.
Last Updated:
Gardasil Lawsuit Updates
Gardasil vaccine lawsuits are still active, but things are moving slowly. Around 200 cases are sitting in federal court under MDL No. 3036 (In re: Gardasil Prod. Liab. Lit.) in the Western District of North Carolina.
Most claims center on people saying they developed health problems after the HPV vaccine, including POTS, autoimmune conditions, and reproductive issues. They also argue Merck did not clearly explain possible risks when the vaccine first came out.
The court has already dismissed some claims over legal technicalities and timing. That has slowed things down, and no trials are scheduled for 2026. Appeals are still in progress, but nothing has changed in the case so far.
Before these lawsuits reach court, most people have to go through the National Vaccine Injury Compensation Program first. That step has limited how many cases move forward.
Merck denies the allegations and says the Gardasil vaccine is safe and effective with no proven link to the injuries people claim. As of now, no major settlements or verdicts have been reached.
Gardasil 2026 Updates
June 4, 2026 – Merck Agrees to Settle Most Gardasil Cases
Bloomberg reported that Merck agreed to settle more than 200 Gardasil cases for about $50 million. According to Merck, the agreement resolves all but one of the pending HPV vaccine lawsuits, and it also ends a California state-court case that had been headed to trial. Merck did not admit fault and continues to say Gardasil is safe and effective.
April 1, 2026 – Gardasil MDL Down to About 129 Cases
A federal multidistrict litigation report listed roughly 129 active cases in the Gardasil litigation, out of about 258 filed over the life of the MDL. The relatively small count reflects how many claims had already been dismissed over Vaccine Court timing and federal preemption — not a lack of reported injuries.
March 2026 – Supreme Court Declines to Hear the Appeal
The U.S. Supreme Court declined to review the plaintiffs’ appeal, leaving in place the lower-court rulings that excluded key expert testimony and dismissed many claims on federal preemption grounds. The decision closed the plaintiffs’ last major path to revive the dismissed federal claims.
February 28, 2026 – Merck Discloses a Proposed Settlement
In its annual report, Merck disclosed that it had reached a proposed agreement to resolve the Gardasil litigation, contingent on enough claimants signing on. The disclosure was an early signal that Merck wanted to contain the cases before more evidence was tested at trial.
Gardasil 2025 Updates
November 3, 2025 – Appeals on Dismissed Gardasil Cases
After the September 2025 Fourth Circuit ruling, most attempts to reopen dismissed Gardasil cases came to an end. The court agreed many claims were filed after the three-year Vaccine Court deadline, so federal courts couldn’t take them. A small number of timely claims may still go on in Vaccine Court, but most of the federal cases are basically over.
September 11, 2025 – Fourth Circuit Upholds Gardasil MDL Dismissals
The Fourth Circuit agreed with the dismissal of Gardasil MDL cases tied to late Vaccine Act filings. It also said adding Gardasil to the vaccine injury table is allowed under the Constitution. Plaintiffs argued only Congress could make that change, but the court disagreed. The ruling confirmed that the Department of Health and Human Services can update the vaccine injury table without new laws from Congress.
September 4, 2025 – Fourth Circuit Affirms Gardasil Bellwether Dismissals
The Fourth Circuit upheld the dismissal of three Gardasil bellwether cases because they were filed after the three-year deadline under the Vaccine Act. The court turned down efforts to extend the filing window and looked only at timing, not whether Gardasil caused the health issues being reported. This ruling is separate from earlier decisions and keeps late-filed cases out of the Gardasil MDL.
August 15, 2025 – Vaccine Court Petitions Rising
More people have been filing Gardasil-related claims through the Vaccine Injury Compensation Program in recent months. Attorneys say federal court rulings pushed more claimants to start in Vaccine Court first before trying civil lawsuits.
July 4, 2025 – Appeal Filed
More than 100 Gardasil lawsuits are now on appeal after earlier dismissals by a federal judge. The plaintiffs argue the court was wrong to block their claims, saying there is evidence linking the HPV vaccine to conditions like POTS and ovarian issues.
April 25, 2025 – Appeal Filed
Plaintiffs in the Gardasil MDL appealed several rulings after most of their claims were dismissed by Judge Bell. The case is now before the Fourth Circuit. Their opening brief is due May 27, 2025.
March 12, 2025 – MDL Ruling Favors Merck
The federal judge in the Gardasil MDL ruled in favor of Merck and dismissed the failure-to-warn claims tied to POTS and ovarian issues. The court said Merck could not change its warning label without FDA approval, so those state law claims don’t work in federal court. That took out a major part of the plaintiffs’ case in the MDL. The ruling only affects the federal cases. State lawsuits are still going and are being handled separately under different legal arguments.
March 8, 2025 – Gardasil and Vaccine Court Process
Gardasil is covered under the Vaccine Injury Compensation Program, so claims usually start there before any lawsuit. But it is not listed in the Vaccine Injury Table, which means there are no automatic injuries tied to it. People have to prove the vaccine caused their condition using medical records and sometimes expert opinions, which makes the process more detailed and harder to build.
February 19, 2025 – Trial Postponed
The first Gardasil vaccine lawsuit trial in Los Angeles was paused and moved to a later date after concerns that news coverage around Robert F. Kennedy Jr.’s confirmation as U.S. HHS Secretary could influence jurors. Both sides agreed to delay things to keep the trial fair. The case involves a woman who says Gardasil caused a heart condition that left her in a wheelchair. Merck denies the claim and says the risks were properly shared. The trial is now set for September with a new jury.
January 27, 2025 – Trial Begins
The first jury trial in a Gardasil vaccine lawsuit looked at claims that Merck overstated how safe and effective the vaccine is. The plaintiff says she developed POTS and nerve damage after getting the shot and believes the risks weren’t fully shared. Merck denies that and says its marketing followed the rules, pointing to research and CDC statements that don’t link Gardasil to those conditions.
January 20, 2025 – First Gardasil Trial Set
The first Gardasil vaccine lawsuit trial was set to begin the following week in California
Gardasil 2024 Updates
December 2, 2024 – Gardasil MDL Case Count Rises
The U.S. Judicial Panel on Multidistrict Litigation reported 212 Gardasil vaccine lawsuits are now pending in the federal MDL. The number has been slowly going up over recent months, with more people filing claims over time.
November 23, 2024 – Deadline Extended in Gardasil MDL
Lawyers for the Gardasil vaccine lawsuit plaintiffs were given an extra seven days to respond to Merck’s request to dismiss 16 bellwether cases. The request is based on implied preemption. The new deadline to reply is December 4, 2024.
November 1, 2024 – Gardasil MDL Activity Slows
The Gardasil vaccine lawsuit saw little movement in October, with only a few new cases added. At the same time, key deadlines were still active in the background. Merck’s main motions and expert-related filings were due, while expert review and depositions were scheduled from late October through mid-November. Plaintiffs were also set to file their responses in November.
October 1, 2024 – Gardasil Lawsuit Filings Rise Slightly
As of October 1, about 15 new Gardasil vaccine lawsuits were filed in recent months, bringing the total to 204 pending cases. The numbers have been creeping up slowly, with more people filing claims against Merck over concerns about autoimmune issues and other side effects they say weren’t fully explained with the HPV vaccine.
September 12, 2024 – Appeals Filed in Gardasil MDL
Three women in the Gardasil vaccine lawsuit said they plan to appeal after their cases were dismissed for being filed too late in Vaccine Court. They argued they needed more time because it took a while to connect their health issues to the vaccine, but the judge did not accept that. The cases are now headed to the Fourth Circuit for review.
September 3, 2024 – Slow Growth in Gardasil MDL
Only a few new Gardasil vaccine lawsuit cases were added over the past two months. That brings the total number of pending cases in the MDL to 200.
August 4, 2024 – Four Gardasil Cases Dismissed
Four Gardasil vaccine lawsuits were dismissed because they did not follow the required Vaccine Court process. The law says claims have to start in Vaccine Court within three years of symptoms. Three people filed too late and didn’t properly challenge that ruling before going to court. One person never filed a Vaccine Court claim at all, so that case was also thrown out.
July 18, 2024 – First Gardasil Trial in Two Months
A Gardasil vaccine lawsuit trial in California state court is set for October 7, 2024, in the case Robi v. Merck. The plaintiff says she developed serious side effects after the vaccine, including heart problems and nerve pain.
July 1, 2024 – Case Count
The lawsuit against Gardasil grew only slightly, moving from 194 cases in June to 197 in July 2024 in the federal MDL in North Carolina. The increase has been small and steady, not a sharp jump in filings.
June 12, 2024 – Bellwether Trial Date to Be Set Soon
Lawyers in the Gardasil lawsuit are close to finishing discovery in the early test cases used for bellwether trials. The date for the first federal test trial is expected to be discussed at the next status conference. At the same time, a California state case may go to trial first. That case involves a plaintiff who says she was left bedridden after getting the Gardasil vaccine.
June 3, 2024 – MDL Approaches 200 Cases
The Gardasil vaccine lawsuit MDL now has 184 pending cases. Three months earlier, there were about 140. The growth has been steady but not fast, with more people still filing claims over time.
May 20, 2024 – Dismissal Request Filed
Merck asked the court to dismiss three Gardasil cases from the MDL. The company said the plaintiffs did not first go through the Vaccine Injury Program as required by law. Under the Vaccine Act, people must file in vaccine court before they can sue in civil court.
April 5, 2024 – Study Looks at Possible POTS Link
A new case study found a link between Gardasil and POTS, a condition that causes lightheadedness, fainting, and rapid heartbeat. Researchers in Utah documented a woman who developed POTS shortly after getting the vaccine in 2014. The study suggests the vaccine may trigger autoimmune or autonomic problems as a reaction to a viral component.
March 29, 2024 – Judge Allows Core Claims to Continue
Merck asked the MDL judge to dismiss all Gardasil lawsuits, arguing that failure to warn claims are barred under the Vaccine Act. Judge Kenneth Bell denied the motion, finding that claims of negligent failure to warn and fraudulent concealment are not fully blocked by the law. The ruling clears the way for the litigation to move into its next phase, which could push Merck toward a settlement.
March 1, 2024 – 39 New Gardasil Cases Added to MDL Since January
The Gardasil MDL now has 143 total pending cases. Since the start of the year, 39 new cases have been added.
January 9, 2024 – Judge Meets with Lawyers to Map Out Gardasil MDL Timeline
Judge Conrad met with lawyers today to discuss the status of the Gardasil lawsuits. Both sides agreed on topics including information sharing, Merck’s updates, and how to coordinate with similar cases in California state court. Key deadlines include written discovery by February 15, expert discovery by August 30, and a Daubert hearing in late January 2025 that will likely determine the future of the litigation.
January 1, 2024 – Gardasil MDL Grows by 28 New Cases in One Month
The Gardasil MDL now has 132 pending cases. That is an increase of 28 new cases over the last 30 days, one of the highest monthly totals since the litigation began.
Gardasil 2023 Updates
December 1, 2023 – Gardasil MDL Reaches 104 Lawsuits
The MDL now has 104 filed lawsuits.
October 2, 2023 – Status Hearing Held
A status hearing was held in the Gardasil MDL last week. Lawyers updated the judge on the dispute over Merck’s document production, limits on discovery, and the bellwether cases.
September 28, 2023 – Case Management Conference
A status conference was held Tuesday in the Gardasil class action. Lawyers discussed the discovery dispute, limits on discovery, and an update on the bellwether cases being prepared for trial.
September 15, 2023 – W hat a Lexecon Waiver Means
Only Gardasil bellwether trial cases have a Lexecon waiver. A Lexecon waiver is an agreement to give up the right to challenge where the trial takes place. This means cases from other states can be tried in North Carolina, so the MDL judge can oversee the trial.
September 1, 2023 – 16 Bellwether Cases Move Forward
In June, both sides picked sixteen bellwether cases for early test trials to help determine settlement amounts. At a pretrial conference this week, lawyers reported that 13 of the 16 plaintiffs have amended their complaints, and Merck has responded. Merck plans to subpoena parents of plaintiffs for depositions since many received the vaccine at a young age. One bellwether case was dismissed and will be replaced to keep the numbers equal.
August 28, 2023 – Gardasil MDL Growth Slows
The Gardasil MDL launched in September 2022 with 20 cases. By January 2023, it tripled to 60 cases, but growth has since flattened. Currently 92 cases are pending, with only 32 new cases added since the start of the year.
August 2, 2023 – Plaintiffs Depose Merck Representatives
A joint status report filed in the Gardasil MDL shows recent developments. Plaintiffs are deposing Merck corporate representatives this week under Rule 30(b)(6). Sixteen bellwether cases are going through discovery, and plaintiffs continue to push Merck for adverse event data that was the subject of an earlier motion to compel.
July 10, 2023 – Merck Fact Sheets Ordered
Under a new order, Merck must fill out a Defendant Fact Sheet for each lawsuit after a plaintiff submits their own Plaintiff Fact Sheet. The DFS is due within 45 days, and the information is treated as if it came from a formal document request. Any documents Merck provides under the DFS are confidential and cannot be shared without permission.
June 27, 2023 – Trial Path Begins to Take Shape
The judge will work with lawyers this week to sort out how the first Gardasil trial will proceed. Sixteen potential cases are in the running to be the first to go to trial. A large verdict would send settlement amounts up, while a dismissal would be disastrous for projected payouts.
June 1, 2023 – Bellwether Trial Plan Set
A bellwether trial program has been set up in the Gardasil class action. In June, an initial pool of 16 cases will be selected, then go through a short fact discovery phase. The pool will then narrow to six cases for the first round of trials next year, all involving patients with POTS or primary ovarian failure.
May 3, 2023 – Court Rules on Plaintiffs’ Expert Reports
The court ruled on a motion about whether plaintiffs could withhold expert reports filed in Vaccine Court. Merck opposed the motion. The court granted it in part, allowing plaintiffs to withhold their own expert reports until they decide if those experts will be consulting or testifying experts in the MDL. If plaintiffs decide not to keep an expert, they must give that report to Merck within 10 days. However, the court denied the request to withhold expert reports filed by the Department of Health and Human Services. The fairness rules do not apply to DHHS experts since plaintiffs will not retain them. Plaintiffs must produce DHHS’s expert reports to Merck within 10 days of the order.
April 14, 2023 – Merck to Produce Adverse Event Documents
In November 2022, plaintiffs filed a motion to compel discovery, saying Merck failed to produce documents about Gardasil adverse event reports. Merck strongly opposed the motion. The judge granted most of the plaintiffs’ requests and ordered Merck to produce all information from its adverse event reporting system and other key documents.
Gardasil Lawsuit Update (July 2026)
Most Gardasil vaccine lawsuits have been settled. In June 2026, Merck agreed to resolve more than 200 Gardasil injury cases for a reported total of roughly $50 million — a settlement the company has said clears all but one of the pending lawsuits over its HPV vaccine.
The deal covers the bulk of the federal cases in MDL No. 3036 (In re: Gardasil Prod. Liab. Lit.) in the Western District of North Carolina, along with a closely watched California state-court case that had been set for trial. Merck has not admitted wrongdoing and continues to maintain that Gardasil is safe and effective; it described the payout as “not material” to the company.
The settlement follows a difficult stretch for plaintiffs. The federal court had dismissed the core failure-to-warn claims on preemption grounds, the Fourth Circuit upheld the dismissal of cases filed after the Vaccine Act’s three-year deadline, and in March 2026 the U.S. Supreme Court declined to take up the plaintiffs’ appeal. Facing those setbacks — and a looming jury trial in California — Merck moved to resolve the litigation rather than test the safety evidence in open court.
For anyone who believes they were injured by Gardasil, two things still matter. First, most claims must begin in the National Vaccine Injury Compensation Program (VICP), and strict deadlines apply — generally three years from the first symptom. Second, because this settlement resolves nearly all of the pending cases, the window for any new claim is narrow and fact-specific. If you or your child experienced a serious health problem after the HPV vaccine, the safest step is to have your situation reviewed promptly so you know whether any options remain.
Find out if you may still have a case — free, confidential review.
How Did Gardasil Rise to Become the Leading HPV Vaccine?
Merck & Company developed the Gardasil vaccine to safeguard against cervical cancer and other illnesses caused by human papillomavirus (HPV), the most common sexually transmitted disease in the United States. The journey of Gardasil began in 1995, when Merck licensed it from various research groups. In January 2006, the vaccine was submitted for the Food and Drug Administration’s approval. Six months later, Gardasil had received approval for females aged 9 to 26. In 2009, the vaccine was also approved for males to prevent anal cancer and genital warts. Gardasil 9, the latest version, was approved in 2014, guarding against nine HPV types. Since its introduction, this vaccine has been hailed as a breakthrough, effectively preventing HPV-related diseases even in non-sexually active children and teens.
How Does Gardasil Work?
Gardasil works by boosting the ability of our immune system to attack HPV types 6, 11, 16, and 18. The vaccine’s purified, inactive proteins from these HPV types stimulate the production of antibodies and immunity against future infections. Gardasil is used to prevent HPV-related diseases.
For girls and women aged 9 through 26:
- Anal cancer
- Anal intraepithelial neoplasia
- Cervical cancer
- Cervical adenocarcinoma in situ
- Cervical intraepithelial neoplasia
- Vaginal cancer
- Vaginal intraepithelial neoplasia
- Vulvar cancer
- Vulvar intraepithelial neoplasia
For males aged 9 through 26:
- Anal cancer from HPV types 16 and 18
- Anal dysplasia from HPV types 6, 11, 16, and 18
- Genital warts from HPV types 6 and 11
- Precancerous lesions from HPV types 6, 11, 16, and 18
How Has Gardasil Evolved Over the Years?
In June 2006, the FDA approved the first Gardasil version, covering HPV types 6, 11, 16, and 18. Later, in December 2014, Gardasil 9 was approved, safeguarding against these four HPV types and five additional ones. Initially for ages 9 to 26, Gardasil 9’s approval was extended to individuals aged 27 to 45 on October 5, 2018.
What Concerns Have Been Raised About Gardasil's Trials and Marketing?
The issues surrounding Gardasil have been a topic of significant debate and concern. Here are the key concerns associated with Gardasil:
- Complete and appropriate medical investigations were not conducted during the pre- or post-approval stages.
- Clinical trials did not examine Gardasil’s potential to prevent cancer; they focused on precursor conditions. Misleading data suggested that these conditions always lead to cancer.
- Merck obtained fast-track FDA approval for Gardasil in June 2006.
- Merck launched an aggressive propaganda campaign, pressuring parents to vaccinate and implying that “good parents” vaccinate their children with Gardasil.
- Unscrupulous marketing tactics were used to exaggerate HPV risks and Gardasil’s efficacy, aiming to encourage mass vaccinations.
- Years of expensive HPV “disease awareness” marketing preceded Gardasil’s rollout to ensure financial success.
- Merck fraudulently concealed the known risks of the HPV vaccine while exaggerating its efficacy during aggressive marketing efforts.
- Political lobbyists and financial incentives were used to make the Gardasil vaccine mandatory for all schoolchildren in some states.
- Gardasil’s efficacy was misrepresented by falsely advertising that it prevents cervical cancer.
- Gardasil increases the risk of developing cervical and other cancers.
- Gardasil induces and increases the risk of many long-term side effects, including autoimmune disorders.
- A small number of doctors against the HPV vaccine have raised concerns about Gardasil’s safety data and how the vaccine was studied in young teens.
What Are the Complications and Side Effects of Gardasil?
Gardasil, while generally safe, has been associated with various severe complications, including but not limited to:
- Acute disseminated encephalomyelitis
- Anal cancer
- Arthritis
- Autoimmune disorders
- Cervical cancer
- Chronic fatigue syndromes
- Chronic inflammatory demyelinating polyneuropathy (CIDP)
- Chronic pain syndromes, including chronic regional pain syndrome (CRPS)
- Coma
- Death
- Dysautonomia
- Epilepsy
- Fibromyalgia
- Guillain-Barre Syndrome (GBS)
- Heart problems, including severe arrhythmia and heart attacks
- Idiopathic thrombocytopenic purpura (ITP)
- Inflammatory disorders
- Interconnective tissue disorder
- Lupus
- Movement disorders
- Multiple Sclerosis (MS)
- Neurological disorders
- Paralysis
- Penile cancer
- Postural orthostatic tachycardia syndrome (POTS)
- Pulmonary embolism
- Reproductive disorders, including premature ovarian failure (POF)
- Rheumatological disorders
- Small fiber neuropathy
- Stroke
- Throat cancer
- Vaginal cancer
- Vulvar cancer
What Is Vaccine Adverse Event Reporting System?
The Vaccine Adverse Event Reporting System (VAERS) is a vital national program managed by the US Centers for Disease Control and Prevention and the FDA. It invites reports of health issues after vaccination from healthcare professionals and the public. Healthcare providers are legally mandated to report specific adverse events, and vaccine manufacturers must report all events they become aware of. This underscores VAERS’ dedication to monitoring vaccine safety. There have been 64,000 Gardasil-related reports in the United States alone, with almost 10,000 being serious and 547 resulting in death.
How to Safeguard Well-being from Gardasil-Related Injuries
Taking proactive steps can safeguard your well-being. Here’s how:
- Stay informed. Before getting vaccinated, educate yourself about Gardasil. Discuss its benefits and potential risks with your healthcare provider. Read the vaccine information sheet and conduct thorough research to make a knowledgeable decision.
- Report side effects. If you notice any side effects post-vaccination, contact your healthcare professional immediately. You can also report these effects to VAERS, aiding in ongoing vaccine safety monitoring.
- Legal guidance. If you’ve been harmed by Gardasil, consult an experienced attorney. They can guide you on the best legal actions based on your vaccine-related injuries, ensuring your rights are protected.
- Explore alternatives. If Gardasil concerns you, discuss alternative HPV prevention options with your healthcare provider. Regular cervical cancer screenings and safe sex practices are viable alternatives worth considering.
- Follow dosing instructions. Adhere to the recommended dosing schedule provided by your healthcare professional. Proper timing ensures maximum protection against HPV, tailored to your or your child’s specific needs.
Steps to Take If You Experience Gardasil Side Effects
If you experience Gardasil side effects, here are some steps you can take:
- Contact your healthcare professional. Contact your healthcare professional if you experience any side effects. They can assess your symptoms and provide suitable treatment.
- Report the side effects. You can report any side effects you experience to the FDA through VAERS. This system is used to report any side effects or adverse events following vaccination.
- Keep track of your symptoms. Record any symptoms you experience after receiving the vaccine. Note when they start, their severity, and how long they last. This record can help if you decide to pursue legal action.
- Consult with a lawyer. Speak with a Gardasil injury lawyer to explore your potential claims in vaccine or civil courts. They can help you understand your legal options and the best steps to take based on your vaccine-related injuries.
- Follow up with your healthcare professional. If you experience any ongoing symptoms or complications after receiving the vaccine, follow up with your healthcare professional for ongoing evaluation and treatment.
Where Can Gardasil Injury Victims Find Support?
Dealing with vaccine-related challenges can be tough. Connecting with others who have faced similar situations can bring comfort and guidance, making your journey easier. Support groups and helplines can provide emotional support and useful resources for you and your family. Here are some organizations and helplines for Gardasil injury victims:
- National Vaccine Injury Compensation Program (VICP). A federal program offering compensation for vaccine-related injuries. Call 1-800-338-2382 or visit their website.
- Immunization Action Coalition: A non-profit providing vaccine safety information and a vaccine injury helpline.
- National Vaccine Information Center: Advocates for informed consent in vaccination, offering a vaccine injury hotline and attorney directory.
- Gardasil Injury Support Group (Facebook): A moderated Facebook group providing a safe space for sharing experiences and finding support.
How to Report Adverse Events of Gardasil to VAERS
What Are Gardasil Vaccine Lawsuits?
The recent evidence linking Gardasil to various autoimmune disorders and other serious health conditions has prompted Gardasil vaccine lawsuits against Merck. Women from all 50 states are filing these cases, alleging that Merck concealed Gardasil’s health risks while falsely promoting it as a cervical cancer prevention vaccine.
In May 2022, the Judicial Panel on Multidistrict Litigation approved a motion to consolidate all Gardasil HPV vaccine lawsuits into a new multidistrict litigation (MDL). The newly formed MDL, In re: Gardasil Prod. Liab. Lit., MDL No. 3036, is assigned to Judge Robert Conrad, Jr., in the Western District of North Carolina.
What Are the Allegations in Gardasil HPV Vaccine Lawsuits?
Allegations in the HPV vaccine lawsuits include:
- Merck didn’t reveal specific Gardasil side effects, preventing informed decisions by individuals and healthcare providers.
- Merck didn’t warn enough about Gardasil’s risks, leaving people unaware before getting vaccinated.
- Merck falsely advertised Gardasil, highlighting benefits while downplaying risks, leading to false confidence.
- Merck falsely advertised and employed unfair practices in promoting Gardasil, breaching consumer protection laws.
- Merck hid crucial Gardasil safety details, misleading healthcare providers and the public.
- Merck neglected safety concerns, ignored reports of adverse events, or didn’t respond appropriately, leading to harm.
- Gardasil had inherent flaws, making it unreasonably unsafe; safer alternatives are available.
- Gardasil caused plaintiffs to develop POI and POTS.
- Individuals claim Gardasil caused their health problems, like autoimmune disorders or neurological issues.
- People weren’t adequately informed about Gardasil’s risks before vaccination, violating their right to make an informed choice.
What Are the Legal Claims in Gardasil HPV Vaccine Cases?
Legal claims in Gardasil class action lawsuits include traditional product liability tort claims. People filing the lawsuits allege they sustained debilitating Gardasil side effects. Some of the specific legal claims in the Gardasil vaccine class action lawsuits are:
- Breach of warranty. Claim that Merck breached express or implied warranties related to Gardasil, asserting that the vaccine did not meet the stated standards or was not fit for its intended purpose.
- Failure to warn. Claim that Merck didn’t give adequate warnings about Gardasil’s risks, leading to uninformed decisions about vaccination.
- Fraudulent concealment. Allegation that Merck fraudulently concealed evidence about Gardasil’s health risks while falsely promoting it as a cervical cancer and other HPV-related disease prevention vaccine.
- Fraudulent misrepresentation. Allegation that Merck lied about Gardasil’s safety and effectiveness, deceiving people into taking the vaccine under false information.
- Manufacturing defect. Claim that Gardasil was defective in its manufacturing, causing injuries to the plaintiffs.
- Negligence. Assertion that Merck’s careless actions in designing, producing, testing, and marketing Gardasil caused harm to the plaintiffs.
- Product liability. Allegation that Gardasil is defective due to design flaws, manufacturing defects, or inadequate warnings, resulting in harm to the plaintiffs.
- Violation of consumer protection laws. Allegation of violations of consumer protection laws, arguing that Merck’s marketing and promotion of Gardasil violated these laws by providing false or deceptive information.
How to Seek Compensation for Your Gardasil-Related Injuries
Anyone who has suffered Gardasil side effects might be eligible for compensation through a federal claims petition or a personal injury lawsuit. Here’s how:
- Speak with a Gardasil injury attorney. Begin by consulting an attorney with experience litigating these types of cases, such as those from firms like Ethen Ostroff Law. They specialize in handling Gardasil-related issues and can guide you through the process.
- Eligibility. Anyone who has suffered Gardasil side effects may qualify to file a lawsuit. The criteria for eligibility vary based on the law firm handling the case.
- Vaccine program. To file a lawsuit, Gardasil vaccine claims must first go through the government’s VCIP. Claimants need to provide evidence of medical treatment and ongoing effects of vaccine-related injuries within a specific timeframe.
- Civil court. After the vaccine program, a lawsuit can be filed in regular court if needed. The process of filing a lawsuit in a regular court is more adversarial, costly, and time-consuming than in the Vaccine Court. Claimants must prove negligence or wrongful actions by the defendant, adhering to specific deadlines depending on the case type and jurisdiction.
How to File a Gardasil Vaccine Claim: Vaccine Court vs. Civil Court
Here are the differences between filing a claim in the vaccine court and a lawsuit in civil court for Gardasil vaccine injuries:
Vaccine court claim:
- Goes through the government’s program, the VICP.
- Must be filed within three years from the first symptoms after vaccination.
- Claimants need to show they received medical treatment and suffered vaccine-related effects for at least six months.
- Lower evidence standard applies (“preponderance of the evidence”).
- Compensation is generally lower than in a personal injury lawsuit.
Civil court lawsuit:
- Can be filed after the vaccine program process.
- Requires proving the defendant’s negligence or wrongful actions.
- Must be filed within specific time limits based on case type and jurisdiction.
- Allows punitive damages for victims.
- Compensation may cover medical expenses, lost wages, emotional trauma, and more.
- Consult a Gardasil vaccine injury attorney for the best legal advice tailored to your specific situation.
Who Is Eligible for A Gardasil Vaccine Lawsuit?
If you or a loved one meets the following criteria, you may be eligible for a Gardasil side effects lawsuit:
- Received the Gardasil vaccine.
- Experienced severe and debilitating side effects or complications after receiving the vaccine, such as cervical cancer, CRPS, GBS, POTS, autoimmune disorders, or other qualifying conditions.
- Can demonstrate that the side effects experienced are directly linked to the Gardasil vaccine (an experienced Gardasil lawsuit attorney can help compile evidence to build the strongest case possible)
- Suffered significant damages as a result, including emotional distress, loss of income, medical expenses, or ongoing treatment costs.
What Is the Timeline for Filing a Gardasil HPV Vaccine Lawsuit?
Filing a lawsuit after a Gardasil vaccine injury follows these general steps:
- Vaccine program. Claims go through VICP and must be filed within three years from vaccination, or two years if the person has passed away. For Gardasil cases, the limit is three years from symptom onset.
- Settlement or lawsuit. After a Vaccine Court decision, claimants can accept the settlement or reject it. If rejected, a lawsuit can be filed within 240 days or directly in civil court against Merck.
The timeline for filing a Gardasil lawsuit may vary depending on the law firm handling the case and the jurisdiction.
How to Join a Gardasil Class Action Lawsuit
Follow these steps to be included in a Gardasil class action lawsuit against Merck:
- Gather records. Collect medical documents from the past two years showing your diagnoses related to Gardasil side effects.
- Educate yourself. Understand how mass tort and class action lawsuits function.
- Decline insurance offers. Avoid accepting any offers from insurance companies regarding your Gardasil-related injuries.
- Consult a lawyer. Reach out to a defective drug lawyer. They’ll assist with paperwork, ensure you meet requirements, adhere to deadlines, and help you secure the best possible Gardasil injury settlement.
How Can a Gardasil Injury Lawyer Help?
When facing the complexities of a HPV Gardasil vaccine lawsuit, having an experienced lawyer by your side is invaluable. Here’s how they can assist you:
- Guidance. Lawyers provide expert guidance on the filing process, ensuring you take the correct legal steps.
- Eligibility check. They assess your eligibility, ensuring you meet the criteria to pursue a Gardasil lawsuit.
- Legal representation. Lawyers represent you in court, simplifying the legal jargon and procedures.
- Evidence gathering. They assist in gathering vital evidence, such as medical records, to strengthen your case.
- Negotiation. Lawyers negotiate on your behalf, aiming for a fair settlement for your Gardasil-related injuries.
- Legal Claims. They help identify the appropriate legal claims, such as negligence or failure to warn, crucial for your case.
- Compensation. Lawyers work to secure compensation covering medical expenses, lost wages, emotional distress, and more, ensuring your rights are protected throughout the process.
What Compensation Can I Get from a Gardasil Lawsuit?
Compensation in Gardasil vaccine lawsuits may include:
- Emotional trauma
- Financial support related to a family member’s death
- Lost wages
- Loss of society and companionship
- Medical expenses incurred
- Medical treatment needed
- Pain and suffering
The compensation for HPV Gardasil vaccine lawsuits may vary depending on the facts of each case, the severity of the injuries, and the jurisdiction. The compensation may be awarded through the vaccine program or a lawsuit in civil court. The compensation through the vaccine program is usually less than through a personal injury lawsuit.
Protect Your Rights with EOL.Law
Understanding one’s rights and seeking compensation is crucial for individuals affected by Gardasil-related injuries. The Gardasil vaccine lawsuits exemplify the complex intersection of public health, scientific research, and legal recourse. While vaccines are vital tools in preventing diseases, the pursuit of vaccine-related litigation underscores the importance of accountability and transparency within the pharmaceutical industry. Armed with knowledge, determination, and legal representation, individuals can protect their rights, seek compensation, and contribute to the ongoing dialogue about vaccine safety and accountability.
For those considering legal action, it is essential to consult attorneys who specialize in vaccine injury cases. At EOL.Law, we offer compassionate help to those impacted by Gardasil-related issues. We provide legal guidance and empathetic assistance tailored to your unique situation. To ensure you’re supported with care and understanding throughout your journey; our team will listen to your concerns, handle the legal processes, and stand by your side.
Give EOL.Law a call today for a free consultation.
Free Gardasil Case Evaluation: Easy Steps, Vital Information
If you or a loved one is considering filing a Gardasil claim, here’s all we need to assist you effectively:
- Full name so we can address you properly.
- E-mail address to communicate updates and information.
- Phone number where we can reach you directly.
- State of residence for legal purposes.
- Receipt of Gardasil to know if you received the Gardasil vaccine.
- Age at the time of receiving the Gardasil vaccine.
- Current age to understand the timeline of events.
- Adverse reactions or side effects that you experienced.
- A brief description of your Gardasil-related experience.
- Whether you’ve filed a case in the Vaccine Court. If yes, we need the details about your Vaccine Court case, if applicable.
- Additional information you’d like to share about your injury.
These details will enable us to evaluate your case thoroughly and support you throughout the process. Your peace of mind matters, and we’re here to simplify the journey for you. Start your free Gardasil case evaluation with EOL.Law now!
Frequently Asked Questions
Can I sue Gardasil?
Yes, but you have to go through the Vaccine Injury Compensation Program first before you can sue Merck. You have three years from your first symptom to file a claim with that program. If that program says no to your claim or you reject their payment offer, then you can take Merck to regular court. A vaccine injury lawyer will look at your case for free and tell you where you stand.
Has the Gardasil vaccine been discontinued?
No, Gardasil 9 is still given to people every day across the country. The older version was phased out several years ago. It got replaced by Gardasil 9, which covers nine strains of HPV instead of four.
Is the Gardasil lawsuit settled?
Yes. In June 2026, Merck agreed to settle more than 200 Gardasil cases for a reported total of about $50 million, and the company has said the deal resolves all but one of the pending HPV vaccine lawsuits. Merck did not admit wrongdoing.
How much is the Gardasil settlement worth?
Reports put the total at roughly $50 million across more than 200 cases. Individual payouts have not been made public and depend on the specific injury and evidence in each case, so there is no set “per person” figure. Anyone included in the settlement should confirm the details with their own attorney.
Can I still file a Gardasil lawsuit in 2026?
It may be difficult. The June 2026 settlement resolves nearly all pending cases, and strict deadlines apply — most Gardasil claims must start in the Vaccine Injury Compensation Program within three years of the first symptom. Whether any option remains is fact-specific, so it’s best to have your situation reviewed as soon as possible.
What injuries are linked to Gardasil in these lawsuits?
The lawsuits most often involve postural orthostatic tachycardia syndrome (POTS), premature ovarian failure and other reproductive problems, and autoimmune or neurological conditions that plaintiffs say developed after the HPV vaccine. Merck disputes that Gardasil causes these conditions.
Do Gardasil claims have to start in Vaccine Court?
Yes, in most cases. Gardasil is covered by the National Vaccine Injury Compensation Program, so claimants generally must file there first — within three years of the first symptom — before bringing a civil lawsuit. Missing that deadline has ended many Gardasil claims.
